RELMADA THERAPEUTICS, INC. ($RLMD)
Filing Information
| Accession Number | 0001213900-26-098969 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
200,000
Total Value
$828,000.00
P&L
-1.7% ($14,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 9, 2026 | Purchase | 100,000 | $4.18 | $418,000.00 | 1,400,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Purchase | 100,000 | $4.10 | $410,000.00 | 1,500,000 | Direct | โ | View Details |